Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.11 USD | +0.04% | +0.39% | +7.76% |
May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.76% | 3.42B | |
-4.54% | 11.52B | |
-4.86% | 8.3B | |
+41.46% | 5.73B | |
-23.53% | 4.69B | |
-18.81% | 2.54B | |
-13.36% | 2.03B | |
-16.39% | 1.86B | |
-31.24% | 1.59B | |
-9.76% | 1.17B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Transcript : Axonics, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-13-2021 12